Bismuth Quadruple Therapy in Helicobacter Pylori Rescue Therapy of Different Tetracycline Doses and Frequencies.
Status:
Recruiting
Trial end date:
2024-06-15
Target enrollment:
Participant gender:
Summary
The researchers collect H.pylori-positive patients who need rescue therapy from the
outpatient clinic. The subjects were randomized to receive a dose and frequency of
tetracycline 500mg tid or qid of bismuth quadruple eradication therapy. 6-8 weeks after
treatment, the subjects will re-take the 13C-urea breath test. Calculate the eradication
rates, adverse reaction rates and patient compliance of each group.
Phase:
Phase 4
Details
Lead Sponsor:
Shandong University
Collaborators:
Peking University Care Luzhong Hospital People's Hospital of Zhengzhou University Taierzhuang District People's Hospital Yuncheng County Hospital of Traditional Chinese Medicine Zibo Central Hospital